Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
ALRT- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial
August 15, 2025Clinical Trials
Read more →